Ricardo Correa, MD, EdD, the director of the University of Arizona endocrinology fellowship, told MedPage Today in 2022 that compounders are probably using the same active pharmacological part [semaglutide], but when you combine things and you add different excipients, the effectiveness if you dont measure that in a randomized controlled trial will not be the same. He added that not knowing exactly what the formulation contains makes prescribing too risky for him and the patient: Youre treating 100 patients and all of them have been doing fine with a compound medication you recommend
Carreno, University of Chile, Chile Reviewed by Helal F
Market Growth The global GLP-1 drugs market size was US$ 48.3 billion in 2024 and is forecast to increase to US$ 52.95 billion by 2025
The inclusion criteria focused on studies published up to July 2024 in English, which evaluate the relevance of oxidative stress biomarkers from different biological samples and their levels compared to control groups, the possible effects of various micronutrients on oxidative stress and brain function, as well as the role of diet in ADHD, with a particular focus on micronutrient supplementation
AOD 9604 Nasal Spray: Fat Loss and Muscle Preservation We go over the advantages of AOD 9604 nasal spray, a peptide intended to preserve muscle and reduce fat
As a triple-agonist that targets GLP-1, GIP, and a third mechanism of action via glucagon receptors in the liver, we are seeing even greater responses in weight loss in the drug trials
